SCHEMBL17209832

SCHEMBL17209832

Cc1cc(C(CN)C(=O)Nc2ccc3cnccc3c2)ccc1OC(=O)C1=CCCC=C1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 20/20 0.62
▸ ROCK1 Q13464 3/20 0.56
▸ MYLK4 Q86YV6 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2775733 0.84 ROCK2 (0.77) ROCK2ROCK1
SCHEMBL2777096 0.82 ROCK2 (0.78) ROCK2
SCHEMBL9883235 0.78 ROCK2 (1.00) ROCK2ROCK1MYLK4
SCHEMBL9883139 0.78 ROCK2 (0.72) ROCK2ROCK1
Hydrochloric Acid SCHEMBL112986 0.77 ROCK2 (0.71) ROCK2ROCK1
SCHEMBL22898421 0.76 ROCK2 (0.78) ROCK2ROCK1MYLK4
SCHEMBL20016619 0.76 ROCK2 (0.82) ROCK2ROCK1MYLK4
SCHEMBL21412790 0.75 ROCK2 (1.00) ROCK2ROCK1MYLK4
SCHEMBL21430778 0.75 ROCK2 (1.00) ROCK2ROCK1MYLK4
SCHEMBL30607236 0.75 ROCK2 (1.00) ROCK2ROCK1MYLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3828172-A1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2021-06-02 — — EP disclosed
EP-2424842-B1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS INC (US) 2015-10-28 — — EP disclosed
Send feedback